Rejected at 12:06 a.m. Nov, 01, 2023 ] by dollajas
Author: seongwj11
Related Note: 1489966899449
Rationale for change

Updates in Sketchypharm

Rejection reason

Discussed with user, need to approach these updates through the formal channels

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::03_Immunosuppressants
#AK_Step1_v12::#UWorld::Step::18707 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::Original_decks::Dorian::im::uw::miscellaneous #AK_Step1_v12::#B&B::13_Immunology::03_Pharm::02_Immunosuppressive_Drugs #AK_Step1_v12::#Physeo::11_Pathology::01_Cardiac_Pathology::02_Hypertension #AK_Step1_v12::#UWorld::COMLEX::26760 #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::01_Cyclosporine #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::07_Immunosuppressants #AK_Step1_v12::#OME::03_Immune::01_Immunology::16_Immunosuppression #AK_Step1_v12::#Pixorize::02_Immunology::05_Cytokines::03_IL-2 #AK_Step1_v12::#UWorld::COMLEX::24266 #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::02_Tacrolimus #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::03_Immunosuppressants #AK_Other::^EXPN #AK_Step1_v12::#UWorld::Step::1155 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::Only_Step_1 #AK_Step1_v12::#UWorld::Step::6685 #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::01_Cyclosporine #AK_Step1_v12::#AMBOSS::6g0jw2 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Cyclosporine #AK_Step1_v12::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::Transplant-Rejection-Prophylaxis #AK_Step2_v12::#Resources_by_rotation::IM::uw::#misc_dorian #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#NBME::21 #AK_Step1_v12::#NBME::30 #AK_Step1_v12::#OME::PreClinical::03_Immune::01_Immunology::16_Immunosuppression #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Tacrolimus #AK_Step1_v12::#AMBOSS::baaHQQ #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::02_Tacrolimus